Triaziquone

Triaziquone

Triaziquone (pronunciation: /traɪˈæzɪkwoʊn/) is a synthetic chemotherapy drug used in the treatment of cancer. It belongs to the class of alkylating agents, which work by damaging the DNA of cancer cells, preventing them from dividing and growing.

Etymology

The term "triaziquone" is derived from the chemical structure of the drug, which contains three (tri-) azo (-az-) groups and a quinone (-quone) group.

Usage

Triaziquone is primarily used in the treatment of various types of cancer, including leukemia, lymphoma, and sarcoma. It is often used in combination with other chemotherapy drugs to increase its effectiveness.

Side Effects

Like all chemotherapy drugs, triaziquone can cause a range of side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include anemia, neutropenia, and thrombocytopenia.

Related Terms

• Alkylating agent
• Chemotherapy
• Cancer
• Leukemia
• Lymphoma
• Sarcoma
• Nausea
• Vomiting
• Hair loss
• Fatigue
• Anemia
• Neutropenia
• Thrombocytopenia

External links

• Medical encyclopedia article on Triaziquone
• Wikipedia's article - Triaziquone

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski